==Instacart (CART) to be acquired by DoorDash (DASH) for $65.00/share

 

• Co announced a definitive agreement under which DoorDash will acquire Instacart for a total value of $65.00 for each Instacart share, or an equity value of approximately $17 billion. The aggregate transaction consideration will be at least 75% cash, with Instacart stockholders able to elect cash, DoorDash stock, or a combination of both, subject to proration so that DoorDash stock does not exceed 25% of the aggregate consideration. Instacart's board of directors has unanimously approved the agreement.
• DoorDash expects many benefits will flow from the transaction, including:
  • More Choice for Consumers: Instacart customers could shop at more than 50,000 additional stores, on top of the nearly 100,000 stores on the Instacart platform today.
  • Two Memberships for the Price of One: DashPass and Instacart+ members would pay one membership fee instead of two, which would save them an estimated $100 million per year on membership fees alone.
  • More Ways to Earn for Dashers and Shoppers: More orders for local businesses can create more earning opportunities, with more choice over when and how they earn, whether that's grocery orders on a quiet day, restaurant orders at peak times, or both.
• The value of $65.00 per Instacart share represents a 26% premium to Instacart's closing price on October 22, 2026, the last trading day before media reports about a possible transaction. Instacart stockholders will have the right to elect to receive, for each Instacart share: (i) $65.00 in cash, (ii) 0.3372 shares of DoorDash common stock, or (iii) a mix of $48.75 in cash and 0.0843 shares of DoorDash common stock, in each case, subject to a cap on the total stock consideration issuable by DoorDash equal to 25% of the aggregate consideration and certain proration mechanics. If stock consideration is oversubscribed, applicable Instacart stockholders will receive stock consideration on a prorated basis.
• DoorDash expects to fund the cash portion of the consideration with cash on hand and proceeds from debt financing. DoorDash has entered into a financing commitment letter with JPMorgan Chase Bank, N.A. providing for a 364-day senior unsecured bridge loan facility in support of the debt component of the transaction, subject to satisfaction or waiver of certain customary conditions. The transaction is not subject to a financing condition. DoorDash is targeting a capital structure that will maintain investment-grade ratings.
• The transaction is expected to close in the end of 2027 or the first half of 2028, subject to approval by Instacart stockholders, the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, other regulatory approvals, including in Canada and Israel, and other customary closing conditions. Stockholders holding about 19% of Instacart's outstanding shares have agreed to vote in favor of the transaction.

===Blue Owl Capital (OWL) reported earnings on Thur 29 Oct 26 (b/o)

 

Blue Owl posts double-digit FRE/DE growth and record institutional fundraising, reiterates faster 2027 management-fee growth outlook

• Q3 EPS $0.24 beat $0.22 consensus; revenue $806.5M (+11% YoY) topped estimates.
• Company declares $0.23 quarterly dividend payable November 23, 2026 to shareholders of record.
• FRE grew 15% and DE 14% LTM; Q3 FRE $0.27, DE $0.24 per share.
• AUM rose 12% YoY to $330 billion; $49 billion raised LTM, record institutional quarter.
• AUM not yet earning fees reached $36 billion, implying about $400 million embedded management-fee growth.
• FRE margin 58.6% YTD, above 58.5% outlook; management expects modest expansion in Q4 and 2027.
• Management reaffirmed 2026 targets to exceed $1.02 FRE/share and $0.89 DE/share.
• Company now consistently over-earns $0.23 quarterly dividend and expects this to continue through 2027+.
• Credit and real assets delivered strong LTM gross returns, led by digital infrastructure at 13.4%.
• Direct lending originations rose to $5.2 billion, but net deployment slightly negative on high repayments.
• Wealth channel improving: inflows up 14% QoQ, OCIC redemptions declining, ORENT redemptions at nine-quarter low.
• Management sees faster management-fee growth in 2027, driven by fee-eligible AUM, new vintages and less offsets.
• Main concern: muted net deployment in direct lending and macro uncertainty could delay translating fundraising into fee-earning AUM.
• Strong quarter, driven by strengthening fee-related earnings, record institutional fundraising, robust investment performance and embedded management-fee growth into 2027.

General Motors (GM) moving from the New York Stock Exchange to Nasdaq

•  Transition Date: GM will trade on the NYSE through November 16, 2026, and is scheduled to begin trading on Nasdaq on November 17, 2026.

• Ticker Symbol: The company will keep its existing ticker symbol, "GM".

• Strategic Reason:  Moving from the NYSE (where GM first listed in 1911) to Nasdaq is part of a broader push to position GM as a technology- and software-driven company focused on autonomous and electric vehicles.

   

Other companies have left the New York Stock Exchange for Nasdaq in recent years, including Walmart and Palantir. The tech-focused exchange has also attracted companies like SpaceX and Anthropic that have recently completed or are attempting initial public offerings at trillion-dollar valuations.

Listing exclusively on the Nasdaq will make G.M. eligible for inclusion in the Nasdaq-100 index, something the company noted in its announcement. 

Being included in the Nasdaq-100, which tracks the largest companies listed on the stock exchange, excluding financial firms, has a lot of advantages. Funds and portfolios tracking the Nasdaq-100 total $1.4 trillion, according to Nasdaq.

OrthoPediatrics (KIDS) reported earnings on Tue 27 Oct 26 (a/h)

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. 

• Sector: Healthcare
• Industry: Medical Devices
• Full Time Employees: 602
• Founded by Erin Springer Yount and Nick A. Deeter in 2006 
• Headquartered in Warsaw, Indiana
• https://www.orthopediatrics.com

IPO Key Details

• IPO Date: October 12, 2017

• Offer Price: $13.00 per share

 

 

 

OrthoPediatrics posts record Q3 2026 revenue $72.7M (+19% YoY), raises 2026 revenue outlook to $270–$273M

• Record Q3 revenue $72.7M, +19% YoY, driven by implants and OPSB growth.
• GAAP EPS loss improved to -$0.25 versus -$0.50 last year.
• Q3 2026 non-GAAP EPS was -$0.23, an improvement of 4% year over year.
• Company missed Q3 2026 EPS estimates but exceeded revenue estimates.
• Adjusted EBITDA reached record $6.9M, ~10% margin, reflecting strong operating leverage.
• Gross margin steady at 74% despite mix shift toward lower-margin but accretive OPSB.
• Free cash flow positive $1.6M versus -$3.4M prior year, guidance reiterated.
• 2026 revenue outlook raised to $270–$273M from $265–$269M, 14–16% growth; EBITDA ~$25M maintained.
• OPSB bracing grew above 20%, now over 60 clinics and 34 systems.
• International revenue rose 18% to $14.8M, led by EMEA; LatAm constrained by set discipline.
• Super Cycle products early but ramping, with major contributions expected in 2027 and beyond.
• Main risks include clinic expansion costs, Brazil/LatAm set pullback, and lumpy 7D and set sales.
• Main concern is sustainability of growth and margin expansion amid clinic investments and cautious LatAm deployment.